CTRI/2022/07/043922
Completed
未知
A comparative study in thrombocytopenia induced by dengue fever or viral fever between kiwi and guava - A Randomized Clinical Trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: A90- Dengue fever [classical dengue]Health Condition 2: B978- Other viral agents as the cause ofdiseases classified elsewhere
- Sponsor
- ONE
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with thrombocytopenia (Low platelet count) induced by dengue fever or any other viral fever
Exclusion Criteria
- •Patients less than 5 years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Platenza Tablets for Dengue feverCTRI/2018/02/011789The Himalaya Drug Company40
Active, not recruiting
Phase 1
Treatment of Low Platelet Counts Due to advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with EltrombopagThrombocytopenic Subjects with Myelodysplastic Syndromes or Acute Myeloid LeukemiaMedDRA version: 14.0Level: LLTClassification code 10028534Term: Myelodysplastic syndrome NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.0Level: LLTClassification code 10060356Term: Acute myeloid leukaemia without mention of remissionSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2011-000114-19-GRGlaxoSmithKline Research and Development Ltd160
Active, not recruiting
Phase 1
Treatment of Low Platelet Counts Due to advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with EltrombopagThrombocytopenic Subjects with advanced Myelodysplastic Syndromes or Acute Myeloid LeukemiaMedDRA version: 14.1Level: LLTClassification code 10028534Term: Myelodysplastic syndrome NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10060356Term: Acute myeloid leukaemia without mention of remissionSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-000114-19-IEGlaxoSmithKline Research and Development Ltd160
Active, not recruiting
Phase 1
Treatment of Low Platelet Counts Due to advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with EltrombopagThrombocytopenic Subjects with advanced Myelodysplastic Syndromes or Acute Myeloid LeukemiaMedDRA version: 14.1Level: LLTClassification code 10060356Term: Acute myeloid leukaemia without mention of remissionSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10028534Term: Myelodysplastic syndrome NOSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-000114-19-CZGlaxoSmithKline Research and Development Ltd160
Active, not recruiting
Not Applicable
Treatment of Low Platelet Counts Due to advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with EltrombopagThrombocytopenic Subjects with Myelodysplastic Syndromes or Acute Myeloid LeukemiaMedDRA version: 14.1Level: LLTClassification code 10028534Term: Myelodysplastic syndrome NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10060356Term: Acute myeloid leukaemia without mention of remissionSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2011-000114-19-NLGlaxoSmithKline Research and Development Ltd160